NeoGenomics (NEO) Peer Comparison
$16.38
$-0.78
(-4.52%)
As on 05-Nov-2026 12:33EST
Market cap
$2,249 Mln
Revenue (TTM)
$788 Mln
P/E Ratio
--
P/B Ratio
2.8
Div. Yield
0 %
Edit
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2,249 | 13,359 | 10,590 | 6,930 | 2,371 |
Revenue ($ Mln) |
788 | 6,338 | 5,674 | 2,661 | 1,959 |
Net Profit ($ Mln) |
-32.30 | 644.40 | 399.12 | 282.40 | 150.09 |
Net Margin (%) |
-4.10 | 10.17 | 7.03 | 10.61 | 7.66 |
RoE (%) |
-3.96 | 18.46 | 16.19 | 33.04 | 17.37 |
Price to Earnings |
-- | 21.74 | 27.01 | 25.61 | 15.95 |
Price-To-Book |
2.81 | 4.82 | 4.25 | 8.04 | 2.67 |
Income Statement ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
787.75 | 6,338.10 | 5,674.31 | 2,661.04 | 1,959.12 |
|
Cost of Revenue
|
442.71 | 3,896.00 | 4,838.38 | 1,818.79 | 1,453.07 |
|
Gross Profit
|
282.54 | 2,564.90 | 799.45 | 758.34 | 471.88 |
|
Operating Expenses
|
392.14 | 1,280.70 | 326.77 | 471.57 | 282.68 |
|
Operating Profit (EBIT)
|
-47.09 | 1,161.40 | 509.16 | 370.86 | 223.38 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-36.18 | 1,065.80 | 532.53 | 382.32 | 203.43 |
|
Provision for Tax
|
-3.88 | 218.80 | 133.02 | 99.92 | 53.34 |
|
Profit after Tax (Net Income)
|
-32.30 | 644.40 | 399.12 | 282.40 | 150.09 |
|
Minority Interest
|
0.00 | -164.20 | -0.39 | 0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 145.70 | 0.00 | 76.75 | 33.68 |
Liabilities ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
800.64 | 2,681.20 | 2,559.31 | 861.42 | 849.62 |
|
Minority Interest
|
0.00 | -164.20 | -0.39 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
460.11 | 3,077.90 | 2,472.09 | 526.08 | 754.07 |
|
Current Liabilities
|
116.17 | 927.40 | 962.91 | 330.93 | 535.73 |
|
Total Liabilities
|
1,359.83 | 7,089.70 | 5,462.97 | 1,640.01 | 2,246.70 |
Assets ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
966.83 | 6,553.50 | 4,843.51 | 1,352.71 | 1,455.34 |
|
Current Assets
|
410.08 | 1,013.00 | 1,154.88 | 365.73 | 684.08 |
|
Total Assets
|
1,359.83 | 7,089.70 | 5,462.97 | 1,640.01 | 2,246.70 |
|
Total Debt*
|
449.14 | 2,803.40 | 2,287.65 | 392.19 | 612.00 |
|
Net Current Assets
|
293.91 | 0.00 | 191.97 | 0.00 | 148.35 |
Cashflow ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
5.23 | 1,175.60 | 564.27 | 388.27 | 271.09 |
|
Cash Flow from Investing Activities
|
-12.34 | -762.80 | -513.18 | -59.34 | -18.30 |
|
Cash from Financing Activities
|
-200.29 | -433.00 | -11.81 | -432.77 | -107.49 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-7.67 | 11.40 | 6.75 | 22.16 | 11.20 |
|
ROE (%)
|
-3.96 | 18.46 | 16.19 | 33.04 | 17.37 |
|
ROA (%)
|
-2.18 | 7.95 | 6.13 | 14.12 | 5.70 |
|
EBIT Margin (%)
|
-4.18 | 18.82 | 9.53 | 14.23 | 11.55 |
|
Net Margin (%)
|
-4.10 | 10.17 | 7.03 | 10.61 | 7.66 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
11.08 | 9.36 | 17.49 | 5.15 | 1.91 |
|
EBIT Growth (%)
|
70.01 | 16.63 | 22.99 | 1.29 | -3.82 |
|
Net Profit Growth (%)
|
71.54 | 19.11 | 21.61 | 1.29 | -7.46 |
|
EPS Growth (%)
|
71.79 | 21.08 | 20.07 | 10.23 | -2.78 |
|
Book Value Growth (%)
|
-4.99 | 15.90 | 20.05 | -11.47 | 2.43 |
Valuation Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-14.01 | 19.12 | 30.03 | 22.57 | 10.92 |
|
Price / Book Value
|
1.81 | 4.44 | 4.63 | 6.11 | 2.09 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-47.18 | 9.54 | 24.49 | 14.37 | 7.17 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.47 | 0.00 | 0.08 | 0.00 | 0.47 |
|
Short term debt to equity ratio
|
0.01 | 0.03 | 0.05 | 0.05 | 0.22 |
|
Current Ratio
|
3.53 | 1.09 | 1.20 | 1.11 | 1.28 |
|
Quick Ratio
|
3.31 | 1.09 | 1.20 | 1.08 | 1.28 |
|
Interest Coverage
|
-10.15 | 9.39 | 66.70 | 78.72 | 7.11 |
Operating Efficiency Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Mednax Inc (MD) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
27.09 | 11.23 | 11.72 | 9.58 | 12.27 |
|
Asset Turnover
|
0.53 | 0.78 | 0.87 | 1.33 | 0.74 |
|
Receivable days
|
77.78 | 37.48 | 43.58 | 25.53 | 49.13 |
|
Inventory Days
|
22.71 | -- | -- | 1.62 | -- |
|
Payable days
|
18.35 | 18.92 | 8.42 | 10.06 | 10.59 |
|
Cash Conversion Cycle
|
82.14 | -- | -- | 17.10 | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
